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Activating receptors in cells of hematopoetic origin
include members of two unrelated protein families,
the immunoglobulin (Ig) and C type lectins, which dif-
fer even in the orientation of the transmembrane (TM)
domains. We examined assembly of four receptors
with diverse function: the NK receptors KIR2DS and
NKG2C/CD94, the Fc receptor for IgA, and the GPVI
collagen receptor. For each of the four different re-
ceptors studied here, assembly results in the forma-
tion of a three-helix interface in the membrane involv-
ing two acidic TM residues from the signaling dimer
and a basic TM residue from the ligand recognition
module, an arrangement remarkably similar to the T
cell receptor (TCR)-CD3 complex. The fact that the TM
domains of Ig family and C type lectins adopt oppo-
site orientations proves that these receptor families
independently evolved toward the same structural ar-
rangement of the interacting TM helices. This assem-
bly mechanism is thus widely utilized by receptors in
cells of hematopoetic origin.
Introduction
Cells of the hematopoetic system continuously monitor
their environment for sudden changes, such as display
of viral peptide-MHC complexes (T cells), upregulation
of stress-induced ligands (NK cells), circulation of anti-
body-decorated pathogens (macrophages and other
phagocytic cells), and exposure of extracellular matrix
proteins at sites of vascular injury (platelets). Each cell
type expresses surface receptors that induce a particu-
lar activation program, and important examples include
the TCR-CD3 complex required for T cell differentiation
and function, a family of NK receptors that trigger lysis
and cytokine production by NK cells, Fc receptors that
induce phagocytosis of antibody-decorated pathogens
and immune complexes, and the glycoprotein VI (GPVI)
collagen receptor that triggers platelet aggregation.
The ligands recognized by these receptors are structur-
ally diverse and include MHC and MHC-like molecules
(TCR, several NK receptors), Igs (Fc receptors), and col-
lagen (GPVI receptor) (Garcia et al., 1999; Colonna and
Samaridis, 1995; Wagtmann et al., 1995; Braud et al.,
1998; Ravetch and Kinet, 1991; Monteiro and Van De
Winkel, 2003; Clemetson et al., 1999). A common fea-*Correspondence: kai_wucherpfennig@dfci.harvard.eduture of these receptors is the absence of signaling mod-
ules in the cytoplasmic domains of the ligand binding
receptor chain(s), which assembles with dimeric-sig-
naling modules with cytoplasmic immunoreceptor tyro-
sine-based activation motifs (ITAMs) that are phosphor-
ylated after receptor triggering. We refer to this group
as “activating immune receptors,” because phosphory-
lation of ITAMs induces a characteristic activation pro-
gram in cells of the immune system, including calcium
flux. Interestingly, these receptors belong to distinct
protein families, the Ig or C type lectin families, which
differ not only in their primary sequence and tertiary
structure but also in the orientation of the TM domains:
the N terminus is located in the extracellular space for
Ig family receptors (type I membrane proteins), but in
the cytoplasm for C type lectin receptors (type II mem-
brane proteins). The TM domains of many of these re-
ceptors carry a basic residue (lysine or arginine) and
associate with signaling dimers with a pair of aspartic
acid TM residues, raising the question of whether these
receptors nevertheless assemble based on the same
mechanism.
The majority of these receptors associate with one
of four known disulfide-linked signaling dimers: ζ, Fcγ,
DAP10, and DAP12. The ζ chain is part of the TCR-CD3
complex (Samelson et al., 1985; Sussman et al., 1988),
whereas Fcγ represents a signaling component for sev-
eral Fc receptors, the GPVI collagen receptor, and other
receptors (Kuster et al., 1990; Tsuji et al., 1997). ζ and
Fcγ have strong sequence homology, in particular in the
TM domains, probably reflecting a gene duplication
event. The cysteine residues that form the interchain
disulfide bond and the aspartic acid residues are lo-
cated in the N-terminal segment of the predicted TM
domains (positions 2 and 6, respectively), and a helical
wheel model of the TM domains indicates that the cys-
teine and aspartic acid residues are located on the
same face of the TM helix (Rutledge et al., 1992). The
two aspartic acid residues of the ζ-ζ and Fcγ-Fcγ di-
mers may thus be positioned at or near the dimer inter-
face. The cytoplasmic domain of ζ has three ITAMs,
compared to the single ITAM of Fcγ. DAP10 and DAP12
represent a second group of disulfide-linked signaling
dimers. DAP10 assembles with the NKG2D receptor ex-
pressed by NK cells and subpopulations of T cells (Wu
et al., 1999), whereas DAP12 (also termed KARAP)
forms the signaling component of a number of activa-
ting receptors, such as the NK receptors KIR (KIR2DS
and KIR3DS) and NKG2C/CD94 (Lanier et al., 1998a;
Lanier et al., 1998b; Tomasello et al., 1998; Wu et al.,
1999; Wu et al., 2000). There is little sequence homol-
ogy to the ζ/Fcγ pair, and the positions of the cysteine
and aspartic acid residues are different: DAP10 and
DAP12 have two cysteine residues per chain in the EC
rather than the TM domain, and the aspartic acid resi-
due is located close to the center rather than in the
N-terminal segment of the predicted TM domain (Fig-
ure 1).
We recently demonstrated that assembly of the TCR-
CD3 complex is organized by interaction of ionizable
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428Figure 1. Topology of Investigated Receptors
(A) The assembly of DAP12 with the NK receptors KIR2DS2 and NKG2C/CD94, which belong to distinct families (Ig and C type lectin,
respectively) and differ in the topology of the transmembrane (TM) domains (indicated by arrows), was examined. Both molecules have a
basic residue within the TM domain (lysine, K) that is required for assembly with DAP12.
(B) The aspartic acid pair (D-D) of the Fcγ-signaling dimer is located in the N-terminal segment of the TM domains, matching the localization
of the basic residue (arginine, R) in the TM domains of the Fc receptor for IgA (FcαRI) and the platelet receptor for collagen (GPVI).
(C) The DAP12 and Fcγ-signaling modules have no sequence homology in the extracellular (EC) and TM domains and differ in the position
and spacing of the cysteine and aspartic acid (labeled as “C” and “D,” respectively) residues that are required for covalent dimer formation
and receptor assembly, respectively.transmembrane residues. Assembly of each of the R
three signaling dimers (CD3δ, CD3γ, and ζ-ζ) with
TCR requires a basic TCR TM residue and a pair of T
facidic residues in the TM domains of the respective sig-
naling dimer (Call et al., 2002). Each assembly step thus t
mresults in the formation of a three-helix interface with
one basic and two acidic TM residues. Both acidic resi- (
adues in the TM domains of a signaling dimer make sim-
ilar contributions to assembly, because a conservative r
lsubstitution from aspartic acid to asparagine in either
CD3δ or CD3 reduced assembly to a similar extent. c
SThese results raised three questions. (1) Does formation
of such a three-helix interface represent a general 1
omechanism for assembly of activating immune recep-
tors with basic TM residues? (2) Is this mechanism also s
Tresponsible for the assembly of receptors that repre-
sent type II membrane proteins in which the TM helix a
Tis in an antiparallel orientation relative to the TM helices
of the signaling dimer? (3) Do the acidic TM residues of w
sa signaling dimer represent a functional pair with which
the basic TM residue of the receptor interacts? We i
Nhave examined these questions for four activating re-
ceptors that are diverse in their sequence, membrane p
ttopology, and function (Figure 1).esults
he structural requirements for assembly were studied
or two human receptors (KIR2DS2 and NKG2C/CD94)
hat associate with the DAP12-signaling dimer but are
embers of different protein families, the Ig family
KIR2DS2) and C type lectins (NKG2C/CD94) (Lanier et
l., 1998a; Lanier et al., 1998b; Wu et al., 2000). These
eceptors are expressed by NK cells and subpopu-
ations of T cells, and receptor activation triggers NK
ell cytotoxicity and cytokine production (Colonna and
amaridis, 1995; Wagtmann et al., 1995; Braud et al.,
998). This prior work had established that members
f these receptor families can assemble with the same
ignaling modules, indicating convergent evolution.
he fact that these receptors are unrelated in sequence
nd structure and differ even in the orientation of the
M domains thus offered an ideal opportunity to assess
hether these receptors had converged on the same
tructural mechanism for receptor assembly. KIR2DS2
s a classical type I membrane protein, whereas
KG2C/CD94 is a heterodimer of type II membrane
roteins whose TM domains run in an antiparallel orien-
ation to those of KIR and the DAP12 dimer (Figure 1A).
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429Figure 2. Cooperative Assembly of KIR and DAP12
(A) The assembly of KIR (KIR2DS2) with DAP12 was examined in an
in vitro translation system with ER microsomes. Membranes were
solubilized with digitonin and complexes isolated by sequential
nondenaturing immunoprecipitation (snIP) utilizing the protein C
(PC) and hemagglutinin (HA) affinity tags on the C terminus of the
two DAP12 chains. After the first IP step with the calcium-depen-
dent PC antibody, complexes were released from IP beads with
EDTA and reprecipitated with the HA antibody. As controls, the PC
(lanes 2 and 6) or HA antibody (lanes 3 and 7) was replaced with
isotype controls. The assembly of KIR with the DAP12 dimer oc-
curred cotranslationally in ER microsomes prior to solubilization,
because no interaction was detected in mixing controls (asterisk,
lanes 4 and 8) in which KIR and DAP12 were assembled in two
separate reactions that were mixed prior to solubilization. Mutation
of the KIR TM lysine to alanine (KIR K/A, lane 5) abrogated in-
teraction with DAP12. The amount of DAP12 covalent dimer
(DAP12 CD) was quantitated by using a phosphor imager and ex-
pressed as a percentage relative to wild-type (wt) (lane 1). DAP12
ND: nondisulfide-linked DAP12 dimer isolated with the IP pro-a phosphor imager demonstrated substantially larger
cedure. The experiment shown is representative of four experi-
ments.
(B and C) The KIR-DAP12 complex contains only a single KIR
chain. Assembly reactions were performed with DAP12 and two
KIR chains (KIR.SBP and KIR.FLAG). Samples were analyzed by
single-step IP for either SBP (lane 1) or FLAG (lane 2) tags or by
two-step snIP (SBP/FLAG) (lane 3). Lanes 4–6 represent mixing
controls. Aliquots of solubilized membranes were analyzed to con-
firm the presence of equal quantities of radiolabeled proteins (C).
The experiment shown is representative of three experiments.The difference in topology of the TM domains thus ex-
cludes the possibility that potential similarities in the
mechanism of receptor assembly can be explained by
a gene or exon duplication event: duplication and inver-
sion of the exon encoding the TM sequence of KIR (or
NKG2C) would not result in a TM domain but rather a
nonsense sequence.
The KIR2DS2 and NKG2C TM domains have no pri-
mary sequence homology, and the critical lysine resi-
dues are located at positions 9 and 15 from the N termi-
nus of the predicted TM domains in KIR and NKG2C,
respectively. The lysines are nevertheless positioned at
a similar depth of the plasma membrane due to the
type I and type II membrane topology of these proteins:
position 9 from the N terminus of the KIR TM domain
and position 9 from the C terminus of the NKG2C TM
domain (Figure 1A).
Cooperativity in the Assembly of KIR with DAP12
Receptor assembly was examined in two- and three-
step sequential nondenaturing immunoprecipitation
(snIP) experiments in order to isolate radiolabeled pro-
tein complexes with defined composition (Call et al.,
2002). The method is based on specialized affinity tags
for elution of protein complexes under nondenaturing
conditions after the first IP, either by addition of EDTA
(calcium-dependent protein C antibody) or competition
with biotin (streptavidin binding peptide [SBP]). Assem-
bly experiments were performed in an in vitro transla-
tion system in which [35S]-labeled membrane proteins
are inserted cotranslationally into ER microsomes. This
system faithfully reproduces membrane protein assem-
bly events defined in cells by metabolic labeling (Ri-
baudo and Margulies, 1992; Huppa and Ploegh, 1997;
Hebert et al., 1998). The advantages of this system are
that the major fraction of radiolabeled protein is synthe-
sized from input RNAs and that the effect of mutations
in any of the receptor components can be assessed by
using relatively low quantities of radiolabeled amino
acids.
The assembly of KIR with the DAP12 dimer was ex-
amined in experiments in which DAP12 chains carried
C-terminal protein C (PC) or hemagglutinin (HA) epitope
tags so that DAP12 dimers with a mutation in only one
of the two chains could be selected. KIR2DS2 specifi-
cally assembled with the DAP12 dimer, as shown by
two-step PC/HA snIP targeting the epitope tags at-
tached to DAP12 chains (Figure 2A, lane 1). This in-
teraction required the TM lysine of KIR, because its
substitution by alanine (KIR K/A) prevented assembly
(lane 5). Quantification of [35S]-labeled proteins using
Immunity
430quantities of the DAP12 covalent dimer (DAP12 CD) in w
nthe presence of KIR (lane 1), compared to reactions in
awhich DAP12 and KIR were translated separately (lanes
d4 and 8, 11.8% and 10.3% of DAP12 dimer relative to
tlane 1, respectively). Efficient formation of DAP12 CD
wrequired the TM lysine of KIR, because the yield of
pDAP12 dimer was reduced to 24.1% for the KIR K/A
cmutant (lane 5). Interaction with the KIR TM domain
Dcontributes substantially to efficient DAP12 dimeriza-
tion, indicating that formation of the three-chain
BDAP12-KIR complex is a cooperative assembly event.
fThe presence of two acidic residues within the TM
Wdomains of the DAP12 dimer raised the question
cwhether one or two KIR chains could assemble with a
bDAP12 dimer. We addressed this question in assembly
aexperiments in which two KIR chains were used that
bdiffered in MW based on the length of the C-terminal
Daffinity tag (KIR.SBP and KIR.FLAG) (Figure 2B). When
cthe SBP tag was targeted in the IP, KIR.FLAG was not
Dcoprecipitated (lane 1); the second KIR chain was also
Snot coprecipitated in the reverse experiment in which
athe FLAG tag was targeted in the IP (lane 2). In addition,
nno complex containing both KIR.SBP and KIR.FLAG
1was isolated in a two-step SBP/FLAG snIP (lane 3),
aeven though equal amounts of radiolabeled proteins
cwere present in all reactions (Figure 2C). The results
Ddemonstrate that the KIR-DAP12 complex contains
tonly a single KIR chain.
t
rThe TM Aspartic Acid Pair Affects
FDAP12 Dimerization
w
Experiments in a cellular system have shown that mu-
r
tation of the DAP12 TM aspartic acid prevents assem-
h
bly with KIR2DS2 (Lanier et al., 1998a). The two aspar-
b
tic acid residues are located near the center of the TM
i
domains in the DAP12 dimer, and it would be energeti-
h
cally highly unfavorable to expose these two polar side c
chains to the hydrophobic interior of the membrane. w
Because the aspartic acids may be located at or near e
the DAP12 dimer interface and represent a functional K
pair that interacts with the TM lysine of KIR, we exam- D
ined whether substitution of the aspartic acids affects D
DAP12 dimerization. Assembly reactions were per- c
formed with two DAP12 chains in which one or both i
chains carried a mutation of the TM aspartic acid (D) to s
asparagine (N), serine (S), or alanine (A). The two-step
snIP procedure (PC/HA) allowed us to select DAP12 p
dimers in which one of the two aspartic acids (DN, DS, b
and DA combinations) or both (NN, SS, and AA combi- o
nations) were mutated (Figure 3A). Of particular interest d
was the substitution from aspartic acid to asparagine: w
asparagine is not ionizable but has the same size as g
aspartic acid and can serve as both hydrogen bond do- 3
nor and acceptor. Substitution of one or both aspartic b
acids by asparagine (Figure 3A, lanes 2 and 3, respec- w
tively) resulted in substantial increases in the yield of b
DAP12 dimer (240% and 350% relative to wild-type [wt] e
for the DN and NN combinations, respectively). Substi- t
tution of both aspartic acids by serine, whose side
chain is also polar yet shorter than that of asparagine, T
also increased dimerization (lane 5, 160% relative to R
wt), but not to the same extent as the DN or NN substi- M
tutions. The lowest level of DAP12 dimer was observed T
when one aspartic acid was substituted by alanine,hich has a short hydrophobic side chain (DA combi-
ation, lane 6). Analysis of aliquots of the assembly re-
ction under reducing conditions without IP (Figure 3C)
emonstrated that equal quantities of radiolabeled pro-
eins were present in the reactions. DAP12 assembly
as thus most efficient with polar side chains at this
osition in both chains, providing evidence for the lo-
alization of the aspartic acid residues at or near the
AP12 dimer interface.
oth TM Aspartic Acids of DAP12 Are Critical
or Assembly with KIR
e used the same general approach to examine the
ontribution of the aspartic acid pair to DAP12 assem-
ly with KIR and quantitated the amount of DAP12-
ssociated KIR after selection of defined DAP12 dimers
y two-step snIP (PC/HA) (Figure 3D). Because both
AP12 chains were targeted in the IP, the amount of
oprecipitated KIR represented the amount of KIR-
AP12 complex (wt defined as 100% in Figure 3D).
ubstitution of both DAP12 aspartic acids by polar (NN
nd SS combinations) or nonpolar residues (AA combi-
ation) abrogated assembly with KIR (lanes 5, 9, and
3). Furthermore, mutation of only one of the aspartic
cids greatly reduced complex formation: DAP12-asso-
iated KIR was reduced to w4% relative to wt for the
S and tow1% or less for the DA combination, respec-
ively (lanes 7 and 11). Even the conservative substitu-
ion of one aspartic acid to asparagine resulted in a
eproducible reduction of assembly with KIR (to 45%,
igure 3D, lane 3), even though DAP12 dimer formation
as substantially higher for the DN combination (240%
elative to DD, Figure 3A, lane 2). These results were
ighly reproducible, and the quantification is shown
oth for the gel in Figure 3D and the average of four
ndependent experiments. The experiment in Figure 2A
ad demonstrated that assembly of the KIR-DAP12
omplex is cooperative, and lower levels of DAP12
ere isolated for the DS and DA dimers that did not
fficiently assemble with KIR. Inefficient assembly of
IR with these mutants was also reflected by a low KIR/
AP12 ratio (14.8% for the DS dimer and 5.8% for the
A dimer, compared to 100% for the wt DD dimer). We
onfirmed these results by using a different IP strategy
n which all three chains of the complex were directly
elected in a three-step snIP (Figure 3F).
The outcome of the DA and DN substitutions was of
articular interest because very similar findings had
een made for TCR assembly with CD3δ: substitution
f either aspartic acid in the TM domains of the CD3δ
imer by alanine reduced TCR association to <10%,
hereas substitution of either aspartic acid to aspara-
ine gave an intermediate level of assembly (29%–
8%) (Call et al., 2002). These results demonstrate that
oth aspartic acids of DAP12 are involved in assembly
ith KIR (Figure 3E) and that this interaction is remarka-
ly similar to assembly of TCR with its signaling dimers,
ven though the three TM helices are otherwise dis-
inct.
he Three-Helix Assembly Mechanism Is Also
elevant for Receptors with Type II
embrane Topology
hese findings raised the question of whether thisstructural mechanism is also responsible for the as-
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431Figure 3. Both TM Aspartic Acid Residues of DAP12 Participate in the Assembly with KIR
(A–C) Evidence for the localization of the aspartic acid pair at or near the DAP12 dimer interface. Assembly reactions were performed with
two DAP12 chains that carried C-terminal PC or HA tags for isolation of DAP12 dimers in which one or both aspartic acids (labeled “D” within
the figure) were substituted by asparagine (labeled “N” within the figure), serine (labeled “S” within the figure), or alanine (labeled “A” within
the figure). Proteins were separated by SDS-PAGE under nonreducing conditions after PC/HA snIP targeting both DAP12 chains (A) or
under nonreducing (B) and reducing conditions (C) without IP. Dimers representing two wt chains are labeled as DD, whereas mixed dimers
with a mutation of one of the two aspartic acid residues to N, S, or A are labeled as DN, DS, and DA, respectively. DAP12 covalent dimers
are labeled as DAP12 (CD) and DAP12 monomers as DAP12 (M). Representative of three experiments.
(D and E) Critical role of the TM aspartic acid pair of DAP12 for assembly with KIR. Assembly reactions were set up with KIR as well as PC-
or HA-tagged DAP12 chains that had either the wt TM sequence or a substitution of the TM aspartic acid. The two DAP12 chains were
targeted by PC/HA snIP, and associated KIR was quantitated by using a phosphor imager (expressed as percentage relative to wt, lane 1),
both for the experiment shown in this figure and the average of four separate experiments. (E) Schematic of the formation of a three-helix
interface between the DAP12 dimer and KIR in the membrane. Chains are depicted as simplified helical wheels, and the critical residues are
indicated on the DAP12 (“D,” aspartic acid; “A,” alanine) and KIR chains (“K,” lysine).
(F) All chains of the complex were targeted in a three-step snIP: the KIR chain was targeted via a C-terminal SBP tag and complexes eluted
by competition with biotin followed by a PC/HA snIP for the two DAP12 chains. As a control, a two-step PC/HA snIP was performed with
the KIR mutant (KIR K/A). The experiment shown is representative of three experiments.sembly of activating immune receptors that do not be-
long to the Ig superfamily. NKG2C/CD94 is a member of
the C type lectin family and assembles with the DAP12
dimer, an interaction that requires the TM lysine of
NKG2C (Lanier et al., 1998b). It had previously been
shown that NKG2C and CD94 form a heterodimer and
that surface expression of NKG2C requires the pres-
ence of both CD94 and DAP12 (Lanier et al., 1998b).
We examined whether the NKG2C chain, which bears
the TM lysine residue, is sufficient for interaction with
DAP12, or whether CD94 is also required. Assembly re-
actions involving PC- and HA-tagged DAP12 chains as
well as NKG2C and/or CD94 were analyzed by two-step
PC/HA snIP to isolate DAP12-associated proteins(Figure 4A). NKG2C assembled with DAP12 in the pres-
ence and absence of CD94 (lanes 1 and 5), and CD94
was only coprecipitated in the presence of NKG2C
(lanes 1 and 9). When the TM lysine of NKG2C was mu-
tated to alanine (NKG2C K/A), neither NKG2C nor
CD94 were associated with DAP12 (lanes 3 and 7). As-
sembly experiments with two differentially tagged
NKG2C chains demonstrated that only a single NKG2C/
CD94 heterodimer assembles with DAP12 (Figure S1
available online with this article).
We next examined whether assembly of NKG2C with
DAP12 is based on the interaction of ionizable TM resi-
dues, as described above for KIR-DAP12. DAP12 di-
mers with substitution of one or both TM aspartic acid
Immunity
432Figure 4. Structural Requirements for the As-
sembly of NKG2C/CD94 with the DAP12-
Signaling Dimer
(A) The NKG2C chain is sufficient for assem-
bly with DAP12. Assembly reactions were
performed with PC- and HA-tagged DAP12
as well as different combinations of CD94,
NKG2C, and a NKG2C (K/A) mutant. Pro-
teins associated with the DAP12 dimer were
isolated by PC/HA snIP and resolved by
SDS-PAGE. Lanes 2, 4, 6, 8, and 10 repre-
sent mixing controls in which the two tagged
DAP12 chains were assembled separately
from the other protein(s); the corresponding
reactions were combined prior to solubiliza-
tion. The experiment shown is representative
of three experiments.
(B) Both aspartic acid residues of the DAP12
TM domains participate in the assembly with
NKG2C. Translation/assembly reactions were
set up with NKG2C as well as PC- and HA-
tagged DAP12 chains in which the TM
aspartic acid (“D”) was either present or mu-
tated to asparagine, serine, or alanine (“N,”
“S,” and “A,” respectively); reactions were
analyzed as described in Figure 3D.residues were selected by two-step PC/HA snIP as H
Ndescribed above in the KIR experiments, and the
amount of associated NKG2C was quantitated (Figure t
c4B). Substitution of only one of the aspartic acid resi-
dues of DAP12 by either a polar or nonpolar amino acid w
b(DS and DA combinations, lanes 7 and 11, respectively)
greatly reduced the yield of coprecipitated NKG2C (to 4
a7% and 10% relative to wt, respectively). In the pres-
ence of NKG2C, these substitutions also reduced the 5
tyield of DAP12 dimers (lanes 7 and 11), as described
above for KIR. A substantial reduction in the yield of w
icomplex was also observed with the DN combination
(23% relative to DD). These results were highly repro- t
tducible, and the quantification is shown both for the
gel in Figure 4B and the average of three independent i
sexperiments. The striking similarities in the outcome of
this experiment between KIR and NKG2C (Figures 3 a
uand 4) demonstrate that a similar three-helix interface
is formed in the membrane based on the contributions N
tof the three ionizable TM residues, even though the TM
helix of NKG2C has an orientation opposite to that of t
dKIR.
The TM Domains of NKG2C and KIR Are Sufficient L
tfor Assembly with DAP12
The interaction was further defined with a construct i
A(NKG2C-TM) that encoded the TM domain of NKG2C
as well as three N- and C-terminal flanking residues for E
aproper membrane insertion. A methionine initiation co-
don as well as an SBP tag were placed N-terminal to (
lthe TM domain, and complexes were isolated by two-
step snIP targeting the SBP tag of NKG2C-TM and the tA-tag on DAP12 (Figure 5). DAP12 CD and the
KG2C-TM protein were only isolated when the aspar-
ic acids in the TM domains of DAP12 were in the wt
onfiguration (Figure 5A, lane 1, DD), but not when they
ere mutated to asparagine or serine (NN and SS com-
inations, lanes 2 and 3). The mixing control in lane
demonstrated that this interaction was specific, and
nalysis of an aliquot of all reactions without IP (Figure
B) indicated that similar amounts of radiolabeled pro-
eins were present in all reactions. A similar construct
as generated to examine the KIR TM domain, which
ncluded a signal peptide N-terminal to the SBP tag for
his type I membrane protein. A complex representing
he TM domain of KIR and the DAP12 dimer could be
solated in the same fashion, and assembly was again
ensitive to substitution of the DAP12 TM aspartic
cids. Taken together, the experiments shown in Fig-
res 3–5 demonstrate that the assembly of KIR or
KG2C with DAP12 is based on a three-chain interac-
ion in the membrane that is remarkably similar even
hough the receptors belong to protein families with
istinct membrane topology.
imited Changes in the TM Domain Are Sufficient
o Convert an Inhibitory KIR
nto a DAP12-Interacting Protein
ll KIR genes show striking sequence similarities in the
C, TM, and cytoplasmic domains, indicating that they
rose from a common ancestor(s) by gene duplication
Vilches and Parham, 2002; Biassoni et al., 1996; Co-
onna and Samaridis, 1995; Wagtmann et al., 1995), and
he activating KIR2DS2 and inhibitory KIR2DL3 proteins
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433Figure 5. The TM Domains of NKG2C or KIR Are Sufficient for As-
sembly with the DAP12 Dimer
Assembly experiments were performed with NKG2C or KIR TM
constructs with an N-terminal SBP tag, and analyzed by two-step
snIP targeting the SBP tag attached to the KIR or NKG2C TM do-
mains and the HA tag on DAP12. DAP12 CD and associated TM
domains were visualized by SDS-PAGE under nonreducing condi-
tions (A). Aliquots of all reactions were also analyzed without IP to
confirm the presence of similar quantities of radiolabeled proteins
in all reactions (B). TM peptides were resolved on a 12% NuPAGE
Bis-Tris gel. The experiment shown is representative of three ex-
periments.differ in the EC domains only at a few positions. Partic-
ularly revealing is an analysis of their cytoplasmic do-
mains: the inhibitory KIR2DL3 has a long cytoplasmic
tail (L designation) with two immunoreceptor tyrosine-
based inhibitory motifs (ITIMs) (YAQL and YTEL, un-
derlined in Figure 6A), whereas KIR2DS2 has a shorter
cytoplasmic domain. This is due to the presence of a
stop codon within the sequence segment representing
the first ITIM in the inhibitory receptor (YA*L in KIR2DS2
and YAQL in KIR2DL3) (Biassoni et al., 1996). Impor-
tantly, the striking degree of sequence similarity be-
tween the two proteins extends beyond this stop co-
don; even the four-residue motif of the second ITIM is
present in the KIR2DS2 sequence (Figure 6A). These
findings indicate that these KIR genes originated from
a common ancestor with a long cytoplasmic tail. Acti-
vating KIR may thus be the product of limited changes
that inactivated the inhibitory cytoplasmic motifs (suchas the introduction of a stop codon, as in KIR2DS2) and
permitted association with the activating DAP12 dimer.
KIR2DL3 and KIR2DS2 differ at four positions within
the TM domains (Figure 6B), and we examined which
changes in the TM domain of the inhibitory KIR2DL3
protein would be sufficient to permit interaction with
DAP12. The TM sequences of all activating human KIR
are highly related and carry a lysine at position 9 of the
TM domain, whereas an isoleucine is located at this site
in all inhibitory KIR sequences. The inhibitory KIR2DL3
protein failed to assemble with DAP12 (Figure 6D, lane
3), in agreement with studies in cellular systems (Lanier
et al., 1998a). Conversion of the isoleucine at position
9 of the TM of KIR2DL3 to a lysine (lane 4) was suffi-
cient for assembly with DAP12 (44% relative to wt). Ad-
ditional substitutions at TM positions 11 and 13 to
those residues observed in activating KIR (lane 5–7) or
placement of a stop codon within the cytoplasmic tail
of KIR2DL3 at the same position as in the activating
receptor KIR2DS2 (lane 8) did not increase the level of
assembly. The KIR2DL3 protein and its variants with the
long cytoplasmic tail (lanes 3–7) were expressed at a
lower level than KIR2DS2 (lane 1) and the KIR2DL3 mu-
tant with the shortened cytoplasmic tail (lane 8), and
the expression levels were taken into account in the
quantification shown in Figure 6D. Introduction of a ba-
sic TM residue at the appropriate site and introduction
of a stop codon in the cytoplasmic domain thus repre-
sent the minimal changes for the conversion of an in-
hibitory KIR to a receptor that assembles with the
DAP12-signaling module and lacks the inhibitory motifs
in the cytoplasmic domain.
The Three-Helix Assembly Mechanism Is Relevant
for Receptors Expressed by Diverse Cell Types
of Hematopoetic Origin
The receptors described thus far are expressed by NK
cells and subpopulations of T cells. We examined
whether this mechanism also directs the assembly of
receptors expressed by other cell types of hematopo-
etic origin. We chose the Fc receptor for IgA (FcαRI)
that is expressed by cells of the myeloid lineage (neu-
trophils, eosinophils, interstitial dendritic cells, and the
majority of monocytes/macrophages) (Monteiro and
Van De Winkel, 2003; Maliszewski et al., 1990) as well
as GPVI, the major collagen receptor responsible for
platelet activation (Clemetson et al., 1999). The signal-
ing dimer (Fcγ) that associates with these receptors has
a TM sequence distinct from that of DAP12, and the
locations of the aspartic acid pair in the Fcγ dimer and
the basic residue (arginine) in these receptors differ
from DAP12 and its associated receptors (Figure 1B).
Assembly experiments utilizing the same approaches
as described above for KIR and NKG2C demonstrated
that the TM arginine is critical for association of FcαRI
as well as GPVI with the Fcγ dimer (Figure 7A and Fig-
ure S2). Both aspartic acid residues of the Fcγ dimer
contributed to assembly with FcαRI, as the yield of
complex was substantially reduced when only one of
the aspartic acids was substituted by another polar res-
idue (to 16.5% and 19% relative to wt for the DN and
DS combinations, respectively) (Figure 7B). Neverthe-
less, small quantities of complex (5.2% relative to wt)
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434Figure 6. Limited Changes in the TM Domain Are Sufficient for Conversion of an Inhibitory KIR to a Receptor that Assembles with DAP12
(A) Alignment of the cytoplasmic domains of the activating KIR2DS2 and the inhibitory KIR2DL3 receptors.
(B) The differences in the TM domains of the activating KIR2DS2 (left) and the inhibitory KIR2DL3 (right) are highlighted on a helical wheel
representation (green, hydrophobic residues; blue, basic residue; and gray, other changes).
(C and D) Conversion of KIR2DL3 to a DAP12-interacting protein. Assembly reactions were performed with the activating KIR2DS2 receptor
(lane 1, positive control), the inhibitory KIR2DL3 receptor (lane 3) and KIR2DL3 constructs in which one to three residues at positions 9, 11,
and 13 (I-L-I) in the TM domain were changed to those found in the activating KIR (K-P-T), as indicated in the table beneath the gel. In
addition, a construct in which a stop codon was placed into the first ITIM at the same position as in KIR2DS2 was tested in combination with
the positions 9 I/K substitution (lane 8). Complexes were isolated by two-step snIP (PC/HA) that targeted the epitope tags attached to
DAP12 chains. The KIR2DL3 protein and its variants with a long cytoplasmic tail (lanes 3–7) were expressed at a lower level than KIR2DS2
(lane 1) and the KIR2DL3 variant with a truncated cytoplasmic tail (lane 8), as shown by SDS-PAGE analysis of an aliquot of solubilized
membranes not subjected to IP (C). These differences in expression level were taken into account in the quantification of the IP experiments
(average of two experiments).
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Assembly of FcαRI with the Fcγ-Signaling
Dimer Are Similar to Those Defined for In-
teraction of KIR and NKG2C with DAP12
(A) Mutation of the arginine located at posi-
tion 3 of the predicted TM domain of FcαRI
prevents assembly with the Fcγ dimer. As-
sembly reactions were set up with human
FcαRI as well as PC- and HA-tagged Fcγ
chains and analyzed by two-step PC/HA
snIP. Controls were as described in Figure 2.
(B) The contribution of both aspartic acid
residues of Fcγ was examined as in Figure
3 for the KIR-DAP12 interaction. Assembly
reactions were performed with PC- and HA-
tagged Fcγ chains in which one or both
chains had the wt TM sequence or a substi-
tution of the aspartic acid residue; com-
plexes were isolated by two-step PC/HA
snIP. The experiment shown is representa-
tive of three experiments.
(C) The formation of small quantities of com-
plex in the absence of both aspartic acid
side chains was confirmed in an assembly
experiment with SBP-tagged FcαRI and HA-
tagged Fcγ chain in which complexes were
directly isolated by two-step SBP/HA snIP.
Small quantities of complex were recovered
when both aspartic acids of the Fcγ dimer
were substituted by asparagine (NN) or ala-
nine (AA). The experiment shown is repre-
sentative of two experiments.were formed when both aspartic acids were mutated to
alanine, as shown by two-step snIP targeting the SBP
tag attached to FcαRI and the HA-tag attached to Fcγ
(Figure 7C). This situation resembles the interaction of
TCRα with the ζ-ζ dimer in which small quantities of
complex were recovered when mutations were intro-
duced at this interaction site (Call et al., 2002). In both
cases, an arginine is located in the N-terminal part of
the TM domain, closer to the surface of the membrane
than the lysines that mediate the interaction of KIR and
NKG2C with DAP12. The TM aspartic acid pair of Fcγ
was also essential for assembly with the platelet recep-
tor GPVI, but this protein was translated at lower levels
than the other three receptors and therefore studied in
less detail (Figure S1).
Discussion
These data establish that the same structural mecha-
nism is responsible for the assembly of a variety of acti-
vating immune receptors with their signaling-transduc-
ing subunits, despite their diversity in sequence and
membrane topology. The key feature of this assembly
mechanism is the formation of a three-helix interface in
the membrane that is created by a basic TM residue of
the ligand binding subunit and a pair of acidic TM resi-
dues of the relevant signaling dimer. Such three-
helix interactions ensure formation of the appropriate
receptor structures. Assembly based on protein in-
teractions among TM helices rather than extracellular
domains also permits substantial structural diversity of
extracellular domains that bind diverse groups of li-
gands, ranging from soluble proteins (Fc receptors) tomembrane proteins (TCR, NKG2C/CD94) and extracel-
lular matrix proteins (GPVI). This assembly mechanism
is compatible with large conformational changes of the
EC domains upon ligand binding, as well as lateral in-
teractions of EC domains with other membrane pro-
teins.
How do the three polar TM residues interact in the
assembly process? Experiments on model TM domains
demonstrated that placement of a single aspartic acid
in a hydrophobic segment results in formation of di-
mers and trimers, indicating that acidic residues can
interact with each other in the membrane environment
(Zhou et al., 2001; Gratkowski et al., 2001; Senes et al.,
2004). An interaction between acidic residues may re-
quire prior protonation of at least one of the carboxyl
groups or acquisition of a structural water molecule
that is hydrogen bonded between the two carboxyl
groups during partioning into the lipid bilayer. There
may not be a charge imbalance in the assembled struc-
tures, because an aspartic acid pair with a shared pro-
ton would have a net charge of −1, rather than −2 (En-
gelman, 2003; Senes et al., 2004). The experimental
data clearly demonstrate that the charge of the acidic
groups is relevant to the assembly process: substitu-
tion of both aspartic acids by asparagine abrogated as-
sembly for all receptors studied. This substitution is in-
formative because the side chains of asparagine and
aspartic acid have the same size and can serve both
as hydrogen bond donor and acceptor. Assembly was
observed, albeit at a reduced level, when one of the
aspartic acid residues was substituted by asparagine.
Such an asparagine-aspartic acid pair may be similar
to an aspartic acid-aspartic acid pair (with loss of a
certain degree of symmetry) in which one of the acidic
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436groups is protonated because the CONH2 group of as- t
paragine and a COOH group of aspartic acid could both r
donate a proton for interaction with a deprotonated t
COO− group. The mechanism delineated here applies g
to the majority of, but not all, activating receptors in the V
immune system, because basic residues are not pre- c
sent in the TM domains of the B cell receptor, the Fc n
receptor for IgE, and CD16. Polar residues are present i
in the TM domains of these proteins, but whether and p
how they contribute to assembly is not yet known. f
Because a similar structural arrangement underlies l
the formation of a variety of different receptors, it is b
important to ask which mechanisms contribute to p
specificity. The following aspects are particularly rele-
vant. (1) Restricted expression of ligand-recognition n
modules and signaling dimers in the relevant cell t
type(s). Relevant examples are the T cell-specific ex- a
pression of the TCRα/β or TCRγ/δ chains and mega- n
karyocyte/platelet-specific expression of the GPVI col- t
lagen receptor. Several of the signaling adaptors are i
only expressed by a particular cell type (CD3γ, δ, and ) m
or a limited group of hematopoetic cells (ζ, DAP10). (2) r
Matching of the location of the TM aspartic acid pair l
to the position of the basic TM residue in the relevant a
receptor(s). In DAP10 and DAP12, the pair of acidic res- 2
idues is located close to the center of the TM domains, h
matching the position of the basic TM residue of t
NKG2D, NKG2C, and KIR. In contrast, the TM arginine o
of FcαRI and GPVI is located in the N-terminal segment p
of the membrane-spanning segment, corresponding to a
the location of the TM aspartic acid pair of the Fcγ di- t
mer. (3) Packing interactions among the three TM heli- c
ces resulting in steric hindrance for mismatched recep- a
tor-signaling dimer combinations. This mechanism w
accounts for the specificity of DAP10 for NKG2D: due p
to sequence differences between the DAP10 and q
DAP12 TM domains, the human NKG2D receptor as- d
sembles with DAP10, but not DAP12, even though the a
TM aspartic acid pair is located at the same position in m
both signaling dimers (Wu et al., 2000). (4) Contribution t
of EC domains to specificity of assembly. In the TCR- c
CD3 complex, CD3δ interacts with TCRα, whereas T
CD3γ binds to TCRβ. The CD3γ TM domain can be s
replaced with the corresponding segment from CD3δ, f
but replacement of the CD3γ EC domain with the CD3δ i
EC domain interferes with assembly (Wegener et al., a
1995; Call et al., 2002). v
Utilization of the same structural mechanism for the
s
assembly of type I and type II membrane proteins rep-
r
resents a clear-cut example of convergent evolution.
TThe TM domains of the type I membrane protein
DKIR2DS2 and the type II membrane protein NKG2C are
isufficient for assembly with the DAP12 dimer. Only a
single residue within the TM domain of the inhibitory
aKIR2DL3 receptor needed to be changed to enable as-
osembly with DAP12 (Figure 6), and such a limited
dchange may be sufficient due to the dominant contribu-
tion of the ionizable TM residues to the assembly pro-
Ecess. In other cases, additional substitutions may be
required to prevent steric hindrance and improve sur-
cface complementarity among the three interacting TM
H
helices, but the sequence requirements do not appear a
to be strict. Modification of an ancestral gene at a lim- P
ited number of positions may thus represent a common
theme in the emergence of activating immune recep-ors. For several receptors (KIR, CD94/NKG2, and mu-
ine Ly49 families), both activating and inhibitory coun-
erparts have been defined that apparently arose by
ene duplication and diversification (Blery et al., 2000;
ilches and Parham, 2002; Natarajan et al., 2002). The
hanges required for association with an activating sig-
aling subunit may thus have occurred independently
n each of these families as part of the diversification
rocess that created both inhibitory and activating
orms. The difference in the topology of Ig and C type
ectin receptors discussed above excludes the possi-
ility that all activating receptors arose from a common
recursor with a basic TM residue.
Study of the murine Ly49 genes has provided a fasci-
ating example of pathogen-driven evolution of activa-
ing and inhibitory immune receptors. Mouse cytomeg-
lovirus (MCMV) causes severe pathology in 129/J, but
ot C57BL/6, mice. The virus encodes a MHC-like pro-
ein (m157) that engages an inhibitory NK cell receptor
n MCMV-susceptible mice (Ly49I), blocking NK cell-
ediated cytolysis and cytokine production. In MCMV-
esistant mice, the viral protein instead binds to a re-
ated receptor, Ly49H, which assembles with DAP12
nd thus serves an activating function (Arase et al.,
002; Smith et al., 1998). The genes encoding these in-
ibitory and activating forms are highly homologous in
heir sequence, suggesting that one evolved from the
ther in response to selective pressure exerted by a
athogen. Sequence comparison of activating (Ly49H
nd D) and inhibitory (Ly49A, C, G2, and I) Ly49 recep-
ors shows striking parallels to the KIR system dis-
ussed above. The two activating Ly49 receptors have
n arginine at position 13 of the predicted TM domain,
hereas a hydrophobic amino acid is present at this
osition in the inhibitory Ly49 receptors. The TM se-
uences are otherwise very similar, with three or four
ifferences at other TM positions between activating
nd inhibitory Ly49 receptors. The cytoplasmic do-
ains of the inhibitory receptors have a single ITIM;
his motif is not functional in activating receptors, be-
ause the key tyrosine is changed to a phenylalanine.
he viral m157 gene may have evolved to provide a
elective advantage for the virus by inhibiting NK cell
unction, but limited changes in the Ly49 gene, includ-
ng the introduction of a basic TM residue required for
ssembly with DAP12, may have converted it to an acti-
ating receptor that instead enhances the immune re-
ponse of the host to this pathogen. Because Ly49 rep-
esents a homodimer with a basic TM residue in each
M domain, it is possible that it assembles with two
AP12 dimers, a feature that may increase the sensitiv-
ty of receptor signaling.
These results demonstrate that this assembly mech-
nism is responsible for the formation of a wide variety
f activating receptors with diverse functions in many
ifferent cell types of hematopoetic origin.
xperimental Procedures
DNA Constructs and In Vitro Transcription
uman NKG2C, CD94, KIR2DS2, KIR2DL3, GPVI, FcαRI, DAP12,
nd Fcγ sequences were amplified from peripheral blood by RT-
CR. All sequences were cloned into a modified pSP64 vector (pro-
bvided by M. Kozak) with the murine H-2K signal sequence (for type
I membrane proteins). Mutations were introduced by PCR using
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437overlapping primers, and epitope tags were added as in-frame fu-
sions, usually with a three amino acid flexible linker; the sequences
of epitope tags and sources of epitope tag reagents were as pre-
viously described (Call et al., 2002). The KIR, NKG2C, GPVI, and
FcαRI constructs encoded C-terminal SBP tags, and three methio-
nine residues were introduced N-terminal to PC or HA tags in the
Fcγ construct for radiolabeling. The first of two cysteines in the EC
domain of DAP12 was mutated to serine to prevent formation of
disulfide-linked multimers. In vitro transcription was performed
from linearized cDNA constructs by using RiboMax T7 Large-Scale
RNA Production Kit and methyl-7G cap analog (Promega; Madi-
son, WI).
In Vitro Translation and Immunoprecipitation
Each 25 l reaction contained 17.5 l nuclease-treated rabbit retic-
ulocyte lysate (Promega), 0.5 l amino acid mixture minus methio-
nine or methionine/cysteine (Promega), 0.5 l SUPERase-In RNase
inhibitor (Ambion, Austin, TX), 1–2 l [35S]-labeled methionine or
methionine/cysteine (Amersham; Piscataway, NJ), RNA (400 ng for
FcαRI, 800 ng for GPVI, and 100–200 ng for all other chains, based
on translation efficiency), and 2.0 l ER microsomes from a murine
hybridoma (IVD12) as previously described (Call et al., 2002). All in
vitro translation and assembly reactions were performed at 30°C.
An initial translation period of 30 min under reducing conditions
was followed by a 1.5–3 hr assembly period after addition of oxi-
dized glutathione to 4 mM. Reaction volumes were 25–75 l as
required for optimal signal with multistep snIP procedures.
Immunoprecipitation, Electrophoretic Analysis,
and Densitometry
Translation and assembly reactions were stopped by dilution with
1 ml ice-cold, Tris-buffered saline (TBS)/10 mM iodoacetamide, and
microsomes were pelleted (10 min/20,000 × g/4°C) and rinsed. Pel-
lets were resuspended in 400 l solubilization/IP buffer (TBS +
0.5% digitonin [Biosynth International, Naperville, IL], 10 mM io-
doacetamide, 0.1% BSA, 5 g/ml leupeptin, and 1 mM PMSF; with
1 mM CaCl2 when anti-protein C mAb was used), then rotated for
30 min at 4°C. Lysates were precleared for 1 hr with Tris/BSA-
blocked Sepharose 4 beads, and primary captures were performed
overnight at 4°C. Primary IP products were washed twice in 0.5 ml
wash buffer (TBS + 0.5% digitonin, 10 mM iodoacetamide; with 1
mM CaCl2 for anti-protein C mAb binding). Nondenaturing elution
with EDTA (PC tag) or biotin (SBP tag) was performed as described
(Call et al., 2002), and eluted complexes were incubated with sub-
sequent antibodies and protein G-Sepharose 4 beads (Amersham,
Piscataway, NJ) for 2 hr at 4°C and washed. Final precipitates were
digested for 1 hr at 37°C with 500 U endoglycosidase H (New Eng-
land Biolabs, Beverly, MA), separated on 15% SDS-PAGE (all ex-
periments, except Figures 5 and 6) or 12% NuPAGE Bis-Tris gels
(Invitrogen, Carlsbad, CA) (reducing conditions for Figures 3C and
4, nonreducing conditions for all other experiments), transferred to
PVDF membranes, and exposed to phosphor imager plates. Densi-
tometry was performed by using the Wide Line Tool in the Image-
Quant software package (Molecular Dynamics).
Supplemental Data
Supplemental Data include two figures and are available online at
http://www.immunity.com/cgi/content/full/22/4/427/DC1/.
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